Nikolas Krishna, MD
Advanced Heart Failure and Transplant Cardiology · Marietta, GANPI 1205132792
Payments from drug & device makers
Across 480 payments — averaging $324.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$79K
- Boehringer Ingelheim$31K
- Novartis$15K
- Scpharmaceuticals Inc.$9K
- Lilly USA, LLC$7K
- Vifor Pharma, Inc.$7K
- plus $7K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 212 | $79,028 |
| Boehringer Ingelheim | 50 | $30,813 |
| Novartis | 44 | $15,430 |
| Scpharmaceuticals Inc. | 15 | $9,496 |
| Lilly USA, LLC | 5 | $7,020 |
| Vifor Pharma, Inc. | 9 | $6,851 |
| Pfizer | 18 | $3,694 |
| Impulse Dynamics (USA) Inc. | 17 | $659 |
| AstraZeneca | 18 | $439 |
| Merck | 19 | $298 |
| E.r. Squibb & Sons, L.L.C. | 13 | $230 |
| Abiomed | 4 | $221 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $218 |
| Cvrx, Inc. | 5 | $206 |
| Alnylam Pharmaceuticals Inc. | 6 | $158 |
| Livanova USA, Inc. | 2 | $155 |
| Amgen | 3 | $144 |
| Bayer | 4 | $86 |
| Edwards Lifesciences | 3 | $79 |
| Bridgebio Pharma, Inc. | 3 | $72 |
| Johnson & Johnson | 3 | $61 |
| Daiichi Sankyo Inc. | 2 | $55 |
| Actelion Pharmaceuticals US, Inc. | 2 | $53 |
| Philips North America LLC | 1 | $43 |
| Novo Nordisk | 2 | $34 |
| Kestra Medical Technology Services, Inc. | 1 | $33 |
| American Regent | 2 | $28 |
| Lantheus Medical Imaging, Inc. | 1 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Amarin Pharma, Inc. | 1 | $16 |
| Endotronix, Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
How this compares
$155,707 in reported general payments places this provider in the 65th percentile of 40 advanced heart failure and transplant cardiology providers in Georgia.
See all advanced heart failure and transplant cardiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Marietta
- Abdul Latif BikakMarietta$274K
- Brian HowardMarietta$174K
- Youssef NasrMarietta$3K
- Levi MayMarietta$2K
- Chad MaoAtlanta$1.3M
- Andrew DarlingtonFayetteville$1.1M
- Darshak KariaAugusta$908K
- Catherine MartiAthens$652K
- Ugochukwu EgolumGainesville$499K
- Andrew SmithAtlanta$413K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.